Jennifer Ornelas
Dermatology · Sacramento, CANPI 1013332451
Payments from drug & device makers
Across 942 payments — averaging $1339.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$388K
- Dermavant Sciences, Inc.$375K
- AbbVie$297K
- Sanofi US Services Inc.$101K
- Organon$73K
- Verrica Pharmaceuticals Inc.$20K
- plus $9K from 24 others
Across 7 payments — averaging $250.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
- Eli Lilly$603
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 13 | $388,499 |
| Dermavant Sciences, Inc. | 496 | $374,624 |
| AbbVie(2 entities) | 60 | $296,761 |
| Sanofi US Services Inc. | 10 | $101,024 |
| Organon | 56 | $72,570 |
| Verrica Pharmaceuticals Inc. | 17 | $19,754 |
| LEO Pharma Inc. | 15 | $1,680 |
| Incyte Corporation | 54 | $1,139 |
| Regeneron Healthcare Solutions, Inc. | 34 | $1,051 |
| Novartis | 37 | $722 |
| Amgen | 18 | $636 |
| Arcutis Biotherapeutics, Inc. | 19 | $491 |
| UCB, Inc. | 17 | $483 |
| Sun Pharmaceutical Industries Inc. | 20 | $456 |
| Lilly USA, LLC | 21 | $408 |
| Sanofi | 12 | $365 |
| Johnson & Johnson | 7 | $296 |
| Galderma Laboratories, L.p. | 5 | $185 |
| Boehringer Ingelheim | 5 | $136 |
| Janssen Scientific Affairs, LLC | 2 | $133 |
| E.r. Squibb & Sons, L.L.C. | 4 | $116 |
| Pfizer | 6 | $99 |
| Botanix SB Inc | 4 | $81 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $64 |
| Biofrontera Inc. | 2 | $36 |
| Krystal Biotech Inc | 1 | $28 |
| Mimedx Group, Inc. | 1 | $28 |
| Cipher Pharmaceuticals US LLC | 1 | $26 |
| Biocon Biologics Inc | 1 | $26 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$1,261,928 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Sacramento
- Raja SivamaniSacramento$11.8M
- Emanual MaverakisSacramento$3.5M
- Emil TanghettiSacramento$1.2M
- Stephanie leSacramento$1.1M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.